TrialStem cell research & therapy2022

Mid-term prognosis of the stromal vascular fraction for knee osteoarthritis: a minimum 5-year follow-up study.

Shengyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.